RPS6KA1 and central nervous system cancer: In addition, we evaluated P(T359/S363)‐RSK1 levels, also required for activation (Anjum and Blenis, 2008), in grade II‐IV gliomas using the RPPA data from TCGA (Brennan et al., 2013).